Boston Scientific (BSX) Work In Process (2009 - 2026)

Boston Scientific has disclosed Work In Process across 18 years of filings, most recently posting $259.0 million for Q1 2026.

• Work In Process for Q1 2026 came in at $259.0 million, up 18.81% year-over-year; the trailing twelve-month figure through Mar 2026 was $259.0 million (up 18.81% YoY), and the FY2025 annual result was $246.0 million, up 27.46% from the prior year.
• Work In Process came in at $259.0 million for Q1 2026 at Boston Scientific, up from $246.0 million in the prior quarter.
• In the past five years, Work In Process ranged from a high of $259.0 million in Q1 2026 to a low of $142.0 million in Q1 2022.
• The 5-year median for Work In Process is $188.0 million (2024), against an average of $192.2 million.
• Across the five-year window, Work In Process increased 6.82% in 2024 and advanced 27.46% in 2025, its largest moves.
• Boston Scientific's Work In Process stood at $147.0 million in 2022, then gained by 18.37% to $174.0 million in 2023, then grew by 10.92% to $193.0 million in 2024, then rose by 27.46% to $246.0 million in 2025, then climbed by 5.28% to $259.0 million in 2026.
• The last three Work In Process figures came in at $259.0 million (Q1 2026), $246.0 million (Q4 2025), and $245.0 million (Q3 2025), per Business Quant data.